{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,6]],"date-time":"2025-07-06T04:42:04Z","timestamp":1751776924304,"version":"3.33.0"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archives of Biochemistry and Biophysics"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.abb.2024.110286","type":"journal-article","created":{"date-parts":[[2024,12,31]],"date-time":"2024-12-31T00:02:39Z","timestamp":1735603359000},"page":"110286","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Discovery of anti-tumor small molecule lead compounds targeting the SH3 domain of c-Src protein through virtual screening and biological evaluation"],"prefix":"10.1016","volume":"764","author":[{"given":"Haifang","family":"Hao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuan","family":"Bian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Na","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xingzhao","family":"Ji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Bao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kongkai","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.abb.2024.110286_bib1","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1593\/neo.10328","article-title":"SRC: a century of science brought to the clinic","volume":"12","author":"Aleshin","year":"2010","journal-title":"Neoplasia"},{"issue":"19 Pt 1","key":"10.1016\/j.abb.2024.110286_bib2","doi-asserted-by":"crossref","first-page":"6924","DOI":"10.1158\/1078-0432.CCR-05-0757","article-title":"Dasatinib (BMS-354825) tyrosine kinase inhibitor suppresses invasion and induces cell cycle arrest and apoptosis of head and neck squamous cell carcinoma and non-small cell lung cancer cells","volume":"11","author":"Johnson","year":"2005","journal-title":"Clin. Cancer Res."},{"issue":"20","key":"10.1016\/j.abb.2024.110286_bib3","doi-asserted-by":"crossref","first-page":"9185","DOI":"10.1158\/0008-5472.CAN-05-1731","article-title":"Action of the Src family kinase inhibitor, dasatinib (BMS-354825), on human prostate cancer cells","volume":"65","author":"Nam","year":"2005","journal-title":"Cancer Res."},{"issue":"14","key":"10.1016\/j.abb.2024.110286_bib4","doi-asserted-by":"crossref","first-page":"9696","DOI":"10.1074\/jbc.M112.419713","article-title":"A truncated fragment of Src protein kinase generated by calpain-mediated cleavage is a mediator of neuronal death in excitotoxicity","volume":"288","author":"Hossain","year":"2013","journal-title":"J. Biol. Chem."},{"issue":"5","key":"10.1016\/j.abb.2024.110286_bib5","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1158\/1078-0432.CCR-05-2692","article-title":"Treatment for advanced tumors: SRC reclaims center stage","volume":"12","author":"Summy","year":"2006","journal-title":"Clin. Cancer Res."},{"issue":"2\u20133","key":"10.1016\/j.abb.2024.110286_bib6","first-page":"121","article-title":"Regulation, substrates and functions of src","volume":"1287","author":"Brown","year":"1996","journal-title":"Biochim. Biophys. Acta"},{"issue":"48","key":"10.1016\/j.abb.2024.110286_bib7","doi-asserted-by":"crossref","first-page":"7928","DOI":"10.1038\/sj.onc.1208080","article-title":"The interplay between Src and integrins in normal and tumor biology","volume":"23","author":"Playford","year":"2004","journal-title":"Oncogene"},{"issue":"12","key":"10.1016\/j.abb.2024.110286_bib8","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1038\/sj.onc.1202076","article-title":"Autophosphorylation of Src and Yes blocks their inactivation by Csk phosphorylation","volume":"17","author":"Sun","year":"1998","journal-title":"Oncogene"},{"issue":"4","key":"10.1016\/j.abb.2024.110286_bib9","first-page":"21","article-title":"Historical retrospective of the SRC oncogene and new perspectives","volume":"13","author":"Simatou","year":"2020","journal-title":"Mol Clin Oncol"},{"issue":"6","key":"10.1016\/j.abb.2024.110286_bib10","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1038\/35073094","article-title":"The hunting of the Src","volume":"2","author":"Martin","year":"2001","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"12","key":"10.1016\/j.abb.2024.110286_bib11","doi-asserted-by":"crossref","first-page":"4235","DOI":"10.1016\/j.celrep.2020.03.005","article-title":"c-Src promotes tumorigenesis and tumor progression by activating PFKFB3","volume":"30","author":"Ma","year":"2020","journal-title":"Cell Rep."},{"issue":"6","key":"10.1016\/j.abb.2024.110286_bib12","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1038\/nrc1366","article-title":"A renaissance for SRC","volume":"4","author":"Yeatman","year":"2004","journal-title":"Nat. Rev. Cancer"},{"issue":"4","key":"10.1016\/j.abb.2024.110286_bib13","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.febslet.2009.01.036","article-title":"Intertwined dimeric structure for the SH3 domain of the c-Src tyrosine kinase induced by polyethylene glycol binding","volume":"583","author":"C\u00e1mara-Artigas","year":"2009","journal-title":"FEBS Lett."},{"issue":"26","key":"10.1016\/j.abb.2024.110286_bib14","doi-asserted-by":"crossref","first-page":"12408","DOI":"10.1073\/pnas.92.26.12408","article-title":"Specific interactions outside the proline-rich core of two classes of Src homology 3 ligands","volume":"92","author":"Feng","year":"1995","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"7","key":"10.1016\/j.abb.2024.110286_bib15","doi-asserted-by":"crossref","first-page":"2302","DOI":"10.1073\/pnas.1106799109","article-title":"Src tyrosine kinase phosphorylation of nuclear receptor HNF4\u03b1 correlates with isoform-specific loss of HNF4\u03b1 in human colon cancer","volume":"109","author":"Chellappa","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"53","key":"10.1016\/j.abb.2024.110286_bib16","doi-asserted-by":"crossref","first-page":"7744","DOI":"10.1038\/sj.onc.1204978","article-title":"Mutational analysis of the regulatory function of the c-Abl Src homology 3 domain","volume":"20","author":"Brasher","year":"2001","journal-title":"Oncogene"},{"issue":"20","key":"10.1016\/j.abb.2024.110286_bib17","doi-asserted-by":"crossref","first-page":"3425","DOI":"10.1007\/s00018-011-0638-1","article-title":"Cdk5 targets active Src for ubiquitin-dependent degradation by phosphorylating Src(S75)","volume":"68","author":"Pan","year":"2011","journal-title":"Cell. Mol. Life Sci."},{"issue":"8","key":"10.1016\/j.abb.2024.110286_bib18","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.3390\/cancers12082327","article-title":"Three-dimensional interactions analysis of the anticancer target c-src kinase with its inhibitors","volume":"12","author":"Jha","year":"2020","journal-title":"Cancers"},{"issue":"22","key":"10.1016\/j.abb.2024.110286_bib19","doi-asserted-by":"crossref","first-page":"3227","DOI":"10.1038\/sj.onc.1210414","article-title":"The ERK1\/2 mitogen-activated protein kinase pathway as a master regulator of the G1- to S-phase transition","volume":"26","author":"Meloche","year":"2007","journal-title":"Oncogene"},{"issue":"22","key":"10.1016\/j.abb.2024.110286_bib20","doi-asserted-by":"crossref","first-page":"3291","DOI":"10.1038\/sj.onc.1210422","article-title":"Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer","volume":"26","author":"Roberts","year":"2007","journal-title":"Oncogene"},{"issue":"2","key":"10.1016\/j.abb.2024.110286_bib21","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1038\/72799","article-title":"A genome-wide survey of RAS transformation targets","volume":"24","author":"Zuber","year":"2000","journal-title":"Nat. Genet."},{"issue":"7","key":"10.1016\/j.abb.2024.110286_bib22","doi-asserted-by":"crossref","first-page":"3450","DOI":"10.1091\/mbc.e03-11-0807","article-title":"The transcriptional response to Raf activation is almost completely dependent on Mitogen-activated Protein Kinase Kinase activity and shows a major autocrine component","volume":"15","author":"Schulze","year":"2004","journal-title":"Mol. Biol. Cell"},{"issue":"23","key":"10.1016\/j.abb.2024.110286_bib23","doi-asserted-by":"crossref","first-page":"3965","DOI":"10.1021\/jm0102250","article-title":"Optimization of 4-phenylamino-3-quinolinecarbonitriles as potent inhibitors of Src kinase activity","volume":"44","author":"Boschelli","year":"2001","journal-title":"J. Med. Chem."},{"issue":"49","key":"10.1016\/j.abb.2024.110286_bib24","doi-asserted-by":"crossref","first-page":"5606","DOI":"10.1038\/sj.onc.1203877","article-title":"Focal adhesion kinase: a regulator of focal adhesion dynamics and cell movement","volume":"19","author":"Parsons","year":"2000","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.abb.2024.110286_bib25","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1186\/s12943-018-0908-8","article-title":"Invasion-related circular RNA circFNDC3B inhibits bladder cancer progression through the miR-1178-3p\/G3BP2\/SRC\/FAK axis","volume":"17","author":"Liu","year":"2018","journal-title":"Mol. Cancer"},{"issue":"6508","key":"10.1016\/j.abb.2024.110286_bib26","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1038\/372786a0","article-title":"Integrin-mediated signal transduction linked to Ras pathway by GRB2 binding to focal adhesion kinase","volume":"372","author":"Schlaepfer","year":"1994","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.abb.2024.110286_bib27","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s12860-019-0193-4","article-title":"High resolution crystal structure of the FAK FERM domain reveals new insights on the Druggability of tyrosine 397 and the Src SH3 binding site","volume":"20","author":"Marlowe","year":"2019","journal-title":"BMC Mol Cell Biol"},{"issue":"12","key":"10.1016\/j.abb.2024.110286_bib28","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1038\/nchem.2381","article-title":"Inhibition of human copper trafficking by a small molecule significantly attenuates cancer cell proliferation","volume":"7","author":"Wang","year":"2015","journal-title":"Nat. Chem."},{"issue":"37","key":"10.1016\/j.abb.2024.110286_bib29","doi-asserted-by":"crossref","first-page":"13517","DOI":"10.1073\/pnas.1408601111","article-title":"Antiinfective therapy with a small molecule inhibitor of Staphylococcus aureus sortase","volume":"111","author":"Zhang","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.abb.2024.110286_bib30","article-title":"Discovery of new \u03b1-glucosidase inhibitors: structure-based virtual screening and biological evaluation","volume":"9","author":"Liu","year":"2021","journal-title":"Front. Chem."},{"issue":"28.9.1\u201328.9.14","key":"10.1016\/j.abb.2024.110286_bib31","article-title":"Analysis of protein stability and ligand interactions by thermal shift assay","volume":"79","author":"Huynh","year":"2015","journal-title":"Curr Protoc Protein Sci"},{"issue":"12","key":"10.1016\/j.abb.2024.110286_bib32","doi-asserted-by":"crossref","first-page":"4701","DOI":"10.1021\/jm100395q","volume":"53","author":"Huang","year":"2010","journal-title":"J. Med. Chem."},{"issue":"7","key":"10.1016\/j.abb.2024.110286_bib33","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1158\/1535-7163.MCT-16-0013","article-title":"Src as a therapeutic target in biliary tract cancer","volume":"15","author":"Nam","year":"2016","journal-title":"Mol. Cancer Therapeut."},{"issue":"7","key":"10.1016\/j.abb.2024.110286_bib34","doi-asserted-by":"crossref","DOI":"10.1172\/JCI162324","article-title":"Coordinated activation of c-Src and FOXM1 drives tumor cell proliferation and breast cancer progression","volume":"133","author":"Nandi","year":"2023","journal-title":"J. Clin. Invest."},{"issue":"5","key":"10.1016\/j.abb.2024.110286_bib35","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1111\/cas.13572","article-title":"c-Src inhibitor selectively inhibits triple-negative breast cancer overexpressed Vimentin in vitro and in vivo","volume":"109","author":"Lou","year":"2018","journal-title":"Cancer Sci."},{"key":"10.1016\/j.abb.2024.110286_bib36","doi-asserted-by":"crossref","DOI":"10.1038\/srep43106","article-title":"Inhibition of N1-Src kinase by a specific SH3 peptide ligand reveals a role for N1-Src in neurite elongation by L1-CAM","volume":"7","author":"Keenan","year":"2017","journal-title":"Sci. Rep."},{"issue":"15","key":"10.1016\/j.abb.2024.110286_bib37","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1016\/j.febslet.2015.05.033","article-title":"The N2-Src neuronal splice variant of C-Src has altered SH3 domain ligand specificity and a higher constitutive activity than N1-Src","volume":"589","author":"Keenan","year":"2015","journal-title":"FEBS Lett."},{"issue":"5188","key":"10.1016\/j.abb.2024.110286_bib38","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1126\/science.7526465","article-title":"Two binding orientations for peptides to the Src SH3 domain: development of a general model for SH3-ligand interactions","volume":"266","author":"Feng","year":"1994","journal-title":"Science"},{"issue":"46","key":"10.1016\/j.abb.2024.110286_bib39","doi-asserted-by":"crossref","first-page":"35455","DOI":"10.1074\/jbc.M110.145102","article-title":"Crystal structure of the Src family kinase Hck SH3-SH2 linker regulatory region supports an SH3-dominant activation mechanism","volume":"285","author":"Alvarado","year":"2010","journal-title":"J. Biol. Chem."},{"issue":"5","key":"10.1016\/j.abb.2024.110286_bib40","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/j.str.2015.03.009","article-title":"The SH3 domain acts as a scaffold for the N-terminal intrinsically disordered regions of c-src","volume":"23","author":"Maffei","year":"2015","journal-title":"Structure"},{"issue":"6","key":"10.1016\/j.abb.2024.110286_bib41","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.1523\/JNEUROSCI.22-06-02142.2002","article-title":"Expression of a variant form of the glutamate transporter GLT1 in neuronal cultures and in neurons and astrocytes in the rat brain","volume":"22","author":"Chen","year":"2002","journal-title":"J. Neurosci."},{"issue":"5","key":"10.1016\/j.abb.2024.110286_bib42","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1080\/10409238.2018.1495173","article-title":"The Src module: an ancient scaffold in the evolution of cytoplasmic tyrosine kinases","volume":"53","author":"Shah","year":"2018","journal-title":"Crit. Rev. Biochem. Mol. Biol."},{"issue":"5","key":"10.1016\/j.abb.2024.110286_bib43","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1021\/acs.accounts.7b00012","article-title":"Tyrosine kinase activation and conformational flexibility: lessons from src-family tyrosine kinases","volume":"50","author":"Meng","year":"2017","journal-title":"Acc. Chem. Res."},{"issue":"3","key":"10.1016\/j.abb.2024.110286_bib44","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1007\/s00441-023-03765-7","article-title":"Src inhibition induces mitotic arrest associated with chromosomal passenger complex","volume":"392","author":"Yang","year":"2023","journal-title":"Cell Tissue Res."},{"issue":"4","key":"10.1016\/j.abb.2024.110286_bib45","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1182\/blood-2012-07-440644","article-title":"Structural framework of c-Src activation by integrin \u03b23","volume":"121","author":"Xiao","year":"2013","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.abb.2024.110286_bib46","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1021\/ci800324m","article-title":"Identifying and characterizing binding sites and assessing druggability","volume":"49","author":"Halgren","year":"2009","journal-title":"J. Chem. Inf. Model."},{"issue":"3","key":"10.1016\/j.abb.2024.110286_bib47","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s10822-013-9644-8","article-title":"Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments","volume":"27","author":"Sastry","year":"2013","journal-title":"J. Comput. Aided Mol. Des."},{"issue":"21","key":"10.1016\/j.abb.2024.110286_bib48","doi-asserted-by":"crossref","first-page":"6177","DOI":"10.1021\/jm051256o","article-title":"Extra precision glide: docking and scoring incorporating a model of hydrophobic enclosure for protein-ligand complexes","volume":"49","author":"Friesner","year":"2006","journal-title":"J. Med. Chem."}],"container-title":["Archives of Biochemistry and Biophysics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003986124004089?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003986124004089?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,19]],"date-time":"2025-01-19T10:28:07Z","timestamp":1737282487000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003986124004089"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":48,"alternative-id":["S0003986124004089"],"URL":"https:\/\/doi.org\/10.1016\/j.abb.2024.110286","relation":{},"ISSN":["0003-9861"],"issn-type":[{"type":"print","value":"0003-9861"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Discovery of anti-tumor small molecule lead compounds targeting the SH3 domain of c-Src protein through virtual screening and biological evaluation","name":"articletitle","label":"Article Title"},{"value":"Archives of Biochemistry and Biophysics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.abb.2024.110286","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"110286"}}